Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
SIGA	Siga Technologies Inc Manufacturing · Year ended 2025-12-31 · USD	$94.57M	$23.28M	24.6%	11.7%	-31.8%	$0.32
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
PRPH	ProPhase Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.34M	-$14.74M	-339.3%	-420.3%	-35.8%	-$1.74
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
CANF	Can-Fite BioPharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$405.0K	-$9.83M	n/m	-175.8%	-39.9%	-$5.97
QUCY	Quantum Cyber N.V. Manufacturing · Year ended 2025-12-31 · USD	$537.1K	-$16.21M	n/m	n/m	-39.9%	-$2.70
QURE	uniQure N.V. Manufacturing · Year ended 2025-12-31 · USD	$16.10M	-$198.97M	n/m	-100.0%	-40.6%	-$3.46
LYEL	Lyell Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.0K	-$274.45M	n/m	-110.6%	-41.0%	-$16.06
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a
ABVC	Abvc Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$296.0K	-$7.91M	n/m	-71.2%	-41.9%	-$0.39
NKTR	Nektar Therapeutics Manufacturing · Year ended 2025-12-31 · USD	$55.23M	-$164.08M	-297.1%	-182.6%	-43.9%	-$9.73
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
PVCT	Provectus Biopharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$336.1K	-$5.43M	n/m	n/a	-45.5%	-$0.01
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
MRKR	Marker Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.55M	-$12.16M	-343.0%	-72.4%	-46.2%	-$0.79
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
TCRT	Alaunos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.0K	-$4.18M	n/m	-194.0%	-50.0%	-$2.20
NAMS	NewAmsterdam Pharma Co N.V. Manufacturing · Year ended 2025-12-31 · USD	$22.50M	-$203.82M	-905.7%	-29.8%	-50.6%	-$1.72
CELU	Celularity Inc Manufacturing · Year ended 2025-12-31 · USD	$26.55M	-$91.72M	-345.4%	n/a	-51.0%	-$3.59
NTHI	Neonc Technologies Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.0K	-$62.15M	n/m	n/a	-51.8%	-$3.20
GOSS	Gossamer Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$48.47M	-$170.37M	-351.5%	n/a	-57.7%	-$0.75
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20

Rows per page: 2550 100